Navigation Links
Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
Date:3/7/2008


ST. LOUIS, March 7 /PRNewswire-FirstCall/ --

From: Jai P. Nagarkatti, President and CEO

Sigma-Aldrich (Nasdaq: SIAL), Oxford BioMedica (LSE: OXB) and Open Biosystems, Inc., a privately held corporation, have jointly announced a confidential settlement of their patent litigation. Sigma-Aldrich and Oxford BioMedica agreed to dismiss the lawsuit brought against Open Biosystems. Open Biosystems agreed to dismiss its counterclaims in the lawsuit. As part of the settlement Open Biosystems will acquire certain license rights under the Oxford BioMedica patents for use of the LentiVector technology in research activities. Other details of the agreement have not been disclosed

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service.

About Oxford BioMedica plc: Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specializing in cancer immunotherapy and gene-based therapies. The Company was established in 1995, as a spin-out from Oxford University, and is listed on the London Stock Exchange. The Company has a platform of gene d
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
2. Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
3. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
4. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
5. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
6. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
7. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
8. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
9. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
10. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
11. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...30 BioMarin Pharmaceutic...Food and Drug Administration (FDA) has granted orp...DAP), amifampridine phosphate, for the rare autoim...MS). 3,4-DAP has previously received orphan drug ...e Committee for Medicinal Products for Human Use o...
(Date:11/30/2009)...GEN, Nov. 30 Exiqon A/S (NASDAQ OM...ard Medical School ICCB-Longwood Screening Facilit...ning Center of Excellence. ICCB-L supports invest...hospitals and institutions, for high-throughput sc..., MicroRNAs are a novel class of small, non-coding...
(Date:11/30/2009)..., AMSTERDAM, November 30 /PRNewswire-FirstC... scientific, medical and technical products and se...e, its comprehensive biomedical,database which hol...7,000,active, peer reviewed journals. , E...t of new biomedical,and pharmaceutical insights. N...
(Date:11/27/2009)...Nov. 27 Cromoz Inc., located in Re...carbon nanotube-based cancer drug delivery system ...tubes, which have functional groups on the walls t...developed in partnership with the Indian Institute...serves as a drug delivery vehicle with the ability...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...., Sept. 17 Diageo (NYSE: DEO ),the world,s lead...nounce,its sponsorship of a physician,s training p...ues developed by the Medical Society of the State ... by Diageo as an unrestricted grant, is,being deve...assess issues,related to alcohol abuse. This train...
...versity of the Year Announces Potential Breakthrou...titis C., CHICAGO, Sept. 17 The British Midlands...University of Nottingham in the,British Midlands h...of a,possible Hepatitis C Vaccine. The United Kin...tor,generating revenues in excess of $8.6 billion ...
...pt. 17 /PRNewswire-FirstCall/ - Angiotech Pharmace... today that it reached a favourable,agreement with...("Conor"),to settle all outstanding patent litigat...tent. "With this agreement now in place, Angiotec...d enforce our intellectual property should decreas...
Other Biology Technology:Diageo Sponsors Medical Society of the State of New York's Physicians Training Program 2Diageo Sponsors Medical Society of the State of New York's Physicians Training Program 3The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 2The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 2Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 4
(Date:11/30/2009)...OUSTON (Nov. 30, 2009) Scientists and engineers f...ne and energy will come together Dec. 7 with lead...g oil and pumping blood. , Much like moving oil ...ugh the body. Both systems need clean, well-funct... or corrosion, to function efficiently. Both indus...
(Date:11/30/2009)...OBOKEN, N.J. - The inaugural Global Conference on... 3-4, 2009, in Washington, DC, focuses on the conv...ises of critical importance to society. , Th...f research activity around targeted complex system... year,s topic includes Critical Infrastructure Sys...
(Date:11/30/2009)...s global temperatures continue to rise scientists ...tanding how species respond and adapt. In a paper ...Dr Francisco Rodriguez-Trelles and Dr Miguel Rodri...global warming of approximately 0.6˚C has alr...challenge facing ecologists and evolutionary biolo...
Breaking Biology News(10 mins):Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2How can scientists measure evolutionary responses to climate change? 2Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 1Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 1Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 3Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 4Excalibur International Marine 2849 25 Owned by EFT BioTech Holdings 29 Completes Inaugural Passenger Crossing of Taiwan Strait 12858 1Excalibur International Marine 2849 25 Owned by EFT BioTech Holdings 29 Completes Inaugural Passenger Crossing of Taiwan Strait 12858 2Excalibur International Marine 2849 25 Owned by EFT BioTech Holdings 29 Completes Inaugural Passenger Crossing of Taiwan Strait 12858 3
...e than 25 years, stem cells have been defined base...well as multiple different specialized cell types....y powerful, many scientists have sought a more mol...s they express. , Now, a team of Canadian scienti...f a gene called Oct4 considered to be the master r...
...gix, Inc. (OTC Bulletin Board: NRGX) today announc...rnal The Lancet of positive results from the first...nd the first report of direct gene transfer into a...nerative disease. , The open label Phase 1 study,...s disease demonstrated both a lack of adverse even...
...esistance to a retrovirus that infected chimpanzee...ironically may be at least partially responsible f...oday. , These findings, reported by a team of rese...in the June 22 issue of Science, provide a better ...rough the study of an ancient virus called Pan tro...
Other Biology News:Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state 2Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 2Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 3Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 4Ancient retrovirus sheds light on modern pandemic 2Ancient retrovirus sheds light on modern pandemic 3
Mouse Anti-Human Troponin I Monoclonal Antibody, Unconjugated, Clone 22B11 from Santa Cruz Biotechnology, Inc.
Immulon 4 HBX 1x12 Strip from Thermo Scientific
Nar I from Promega
...kinase (rEK) is a highly purified preparation of t...ine protease which recognizes the identical cleava...;) and has similar enzymatic activity. Novagen&'s ...eld the highest activity available, and is qualifi...
Biology Products: